Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children

• Главные авторы: Natividad Viguria (Автор), Ana Navascués (Автор), Regina Juanbeltz (Автор), Alberto Echeverría (Автор), Carmen Ezpeleta (Автор), Jesús Castilla (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2021-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection consultations and hospitalizations in high-risk chi...